Standardized SEC financial data for CURIS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001108205 · NASDAQ · Biological Products, (No Diagnostic Substances).
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $10.8M | $10.6M | $10.2M | $10.0M | $10.9M | $9.4M |
| R&D expense | $23.1M | $34.9M | $43.3M | $39.5M | $38.6M | $28.3M |
| SG&A expense | $12.1M | $17.3M | $19.6M | $18.6M | $16.8M | $14.0M |
| Operating income | -$24.9M | -$42.1M | -$53.0M | -$48.3M | -$44.5M | -$5.7M |
| EBITDA | -$24.8M | -$41.9M | -$52.8M | -$48.1M | -$44.3M | -$5.5M |
| Interest expense | $5.0M | $4.4M | $4.1M | $2.4M | $461K | $1.5M |
| Income tax | — | — | — | — | $0 | $0 |
| Net income | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | -$7.6M |
| EPS (diluted) | $-0.61 | $0.50 | $-12.14 | $-8.96 | $-6.88 | $-0.58 |
Standardized from CURIS INC's SEC filings — per-share figures split-adjusted. Full history via the API.
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CRIS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CRIS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"